Lu et al. showed that inhibition of LOX reduced myocardial fibrosis and cardiac remodeling whereas transforming growth factor-β (TGF-β) induced LOX activity and augmented cardiac fibrosis and heart failure (Lu et al., 2019). The gene discussed is LOX; the disease is heart failure.